Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone hydrochloride plus flurbiprofen axetil for postoperative analgesia in children
ChiCTR2000029193Phase 4Not yet recruiting
- Sponsor
- Xiamen Maternal and Child Health Care Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone, flurbiprofen axetil and sufentanil in postoperative pain (3 arms), sponsored by Xiamen Maternal and Child Health Care Hospital. Primary endpoint: Postoperative FLACC score. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
hydromorphoneflurbiprofen axetilsufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000029193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029193.